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SUMMARY
We describe two patients with HIV/AIDS who presented pulmonary and intestinal infection caused by Cryptosporidium parvum, 
with a fatal outcome. The lack of available description of changes in clinical signs and radiographic characteristics of this disease 
when it is located in the extra-intestinal region causes low prevalence of early diagnosis and a subsequent lack of treatment.
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INTRODUCTION 
Cryptosporidium parvum is an obligate intracellular parasite of the 
Coccidia class that infects the microvilli epithelial cells of the digestive 
and respiratory systems1. This parasite is responsible for causing severe 
diarrhea in approximately 55% of human immunodeficiency virus/
acquired immune deficiency syndrome (HIV/AIDS) patients living in 
developing countries2.
Among the 16 currently described species of Cryptosporidium, C. 
parvum and C. hominis are those that predominate in immunocompromised 
individuals3. 
Infection occurs after ingestion of water or food contaminated with 
oocysts or direct person-to-person or animal-person contact4. Respiratory 
forms of infection can happen upon inhalation of oocysts during an 
episode of vomiting5,6.
Studies by LOPEZ-VELEZ et al.7 and CLAVEL et al.8 found 
that 30.2% of patients with intestinal cryptosporidiosis also carried 
extraintestinal infections in both the lungs and bile. The studies mentioned 
above reported high mortality rates amongst the patients as these cases 
showed dramatically lower CD4 + cell counts, ultimately reflecting a 
very severe degree of immunosuppression. 
Therefore, we decided it to be of clinical and educational significance 
to report our finding of C. parvum (identified by molecular testing) in 
fecal samples and sputum from two HIV/AIDS patients.
This study was submitted and approved by the Research on Human 
Beings Ethics Committee of the Marília Medical School (FAMEMA), 
under the number 33677514.1.0000.5413. Figure 2 was made using the 
medical records of patients what are in the custody of the Serviço de 
Prontuário de Paciente (SPP) of Marília Medical School. Similarly, 
the blades for the manufacture of Figure 3 were photomicrographed in 
Olympus microscope BX41 model coupled to a digital video camera, 
Olympus, DP 25 model, DP2-BSW software, Olympus, originals of 
FAMEMA Parasitology and Microbiology Laboratories.
Patient history
Case 1: 
On 10/06/2013, a fifty-nine-year-old female patient sought medical 
care at the emergency ward of the Marilia Clinical Hospital. The 
patient reported a two-month-long history of diarrhea, along with oral 
moniliasis associated with weight loss of 15 kg +/- over this period. 
She denied any fever, cough, urinary changes or emesis. The patient 
reported one prior medical consultation within Brazil’s Specialized 
Care Service (SAE) with the same story and referring indication of 
highly active antiretroviral therapy (HAART), however, without any 
confirmed CD4 + result. 
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On the day of treatment, the patient had a physical examination that 
determined a poor general condition: pale; dehydrated; Heart rate: 68 
bpm; Blood pressure: 80 x 50 mmhg; afebrile.
Lungs: Vesicular murmur: present with bibasilar crepitant rales. 
Heart: S1 and S2 heart sounds normal and regular; without murmurs.
Abdomen: excavated, bowel sounds present and hypoactive, limp 
and painless.
Lower limb: weak pulse, with capillary refill time: 3 seconds. 
At this time, supportive measures were instituted, including a broad 
spectrum treatment for opportunistic diseases. Laboratory tests were 
requested, including for detection of Cryptosporidium spp., which 
ultimately proved positive in both stool samples (method Kinyoun) and 
sputum (the Ziehl-Neelsen). 
Case 2:
On 10/18/2013, a forty-four-year-old female patient was admitted to 
the Infectious Diseases Ward of Marilia Clinical Hospital. The patient 
reported experiencing diarrhea for approximately the previous three 
months. During this period, the patient experienced a weight loss of 10 
kg, associated with an unmeasured fever and dry cough. On the day of 
admission, the patient presented a normal general condition: conscious, 
oriented, dehydrated and pale. Heart: S1 and S2 heart sounds normal; 
without murmur Heart rate: 86 bpm, Lungs: Vesicular murmur: present, 
no adventitious sounds (Saturation: 98%).
Supportive measures and laboratory tests were performed. 
Treatment of esophageal candidiasis was initiated upon hospitalization. 
An Acid-Alcohol Resistant Bacilli (AARB) exam was performed with 
negative results, and the analysis of stool and sputum samples for 
Cryptosporidium returned positive.
Molecular testing: Stool and sputum samples from both patients 
were submitted to a specific detection of Cryptosporidium using 
Nested PCR method. The fragment of the 18S rRNA subunit was 
amplified by nested PCR by using the forward primers: SCL1F 
5’-CTGGTTGATCCTGCCAGTAG-3’ and reverse CPB-DIAGR 
5’-AAGGTGCTGAAGGAGTAAGG-3’ which amplify 1035 pb and 
SSU F 5’-GGAAGGGTTTTTATTGTAAGATAAAG-3’ and SSUR 
5’-AAGGAGTAA GGATCCACCACAA- 3’ which amplify about 826 pb 
as previously described by COUPE et al.9 and XIAO et al.10 to identify 
of Cryptosporidium spp. The fragments of the secondary PCR were 
purified with GFXTM PCR DNA Gel Band Purification Kit (GE-UK) and 
directly sequenced. The nucleotide sequences obtained were analyzed 
and compared with those registered in GenBank, and phylogenetic 
analysis were used on the aligned sequences to assess relationships among 
sequences that allowed the identification of Cryptosporidium parvum in 
both patients.
DISCUSSION 
The low number of diagnosed cases of extraintestinal cryptosporidiosis, 
Fig. 3 - A: Cryptosporidium spp. oocysts in faeces stained by the Kinyoun method. B: 
Cryptosporidium spp. oocysts in sputum stained by the Ziehl-Neelsen method. 
Fig. 2 - A: Nonspecific radiographic changes presented by Patient 1. B: Patient 2 without 
significant radiographic changes.
Fig. 1 - A phylogenetic tree was inferred using the neighbor-joining method28 with 1000 
bootstrap replicates, and evolutionary distances calculated using the Kimura 2-parameter29 
method. Evolutionary analyzes were performed by MEGA5 software30.
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especially of pulmonary location, is largely due to the absence of specific 
clinical signs, as well as the presence of radiological abnormalities, which 
can be confused with other opportunistic infections that commonly affect 
patients with immune impairment.
In our cases, parasitological examination by Ziehl-Neelsen and 
Kinyoun techniques demonstrated the presence of Cryptosporidium spp. 
in the sputum and stool (Fig. 3) of two patients. Confirming the presence 
of the specific species, C. parvum, was performed by nested PCR of the 
18S rRNA region in sputum and feces of patient 2, and sputum of patient 
1. Sequencing of the samples was then performed and aligned with the 
sequences available in the GenBank database, showing similarity with 
the C. parvum species, as can be observed in Figure 1. 
There is no sufficient molecular data available to support information 
on the prevalence of C. parvum in clinical cases in Brazil. ASSIS et al.11 
detected Cryptosporidium parvum in 10 HIV-positive patients in Minas 
Gerais, suggesting a possible zoonotic transmission of this species 
of Cryptosporidium. However, many studies showed that C. hominis, 
along with C. parvum, are the most frequent species observe in humans 
worldwide12,13. 
The differentiation of Cryptosporidium to species level depends 
on the identification by specifics molecular methods, which limits 
the availability of information on the spread of this species of 
Cryptosporidium in human clinical cases, mainly in Brazil12. Therefore, 
the epidemiological importance of reporting these cases is bolstered 
by the fact that the transmission of this parasite occurs from person-
person14, since certain promiscuous habits can happen primarily amongst 
practitioners of oro-anal intercourse, putting these individuals at specific 
risk of infection12,15,16.
Although the results demonstrated the presence of C. parvum in 
stool and sputum, indicating the possibility that pulmonary infection has 
occurred through inhalation of oocysts during an episode of vomiting, 
as mentioned by some authors6, one cannot rule out the spread by 
hematogenous route, since it is described as the presence of the parasite 
within macrophages17. 
GENTILE et al.18 reported finding Cryptosporidium oocysts within 
blood vessels and studies of MARTINEZ et al.19 in an in vitro study 
conducted in mice, demonstrated that Cryptosporidium can multiply 
within macrophages, resisting the action of lysosomal enzymes, making 
it difficult to control the infection in immunocompromised patients in 
case that this possibility occurred in humans. 
Although radiographic changes occurred only in Patient 1, (Fig. 2), 
specific treatment for cryptosporidiosis was not instituted, because until 
then there was no effective treatment for cryptosporidiosis in HIV/AIDS 
patients. Several authors showed the limited effectiveness of drugs like 
Nitazoxanide, Macrolides, or Paromomycin for treating cryptosporidiosis 
in immunocompromised patients, even if HAART was associated20,21,22,23. 
Recently, promising results have been obtained by CASTELLANOS-
GONZALEZ et al. (2013)24 when they treated immunosuppressed mice 
infected with C. parvum using Calcium-dependent protein kinases 
inhibitor (CDPK1 inhibitor).
Therefore at this time, we choose to treat the most prevalent infectious 
diseases in these patients, and antiretroviral therapy HAART was initiated 
to recovery the cellular immune system25, since CD4+ cells are decisive 
for the acquired immune response26. However, in a short space of time, 
there was a worsening of the general condition of Patient 1, and she 
progressed to death. In relation to Patient 2, as she had been clinically 
stable, the patient was discharged with guidelines for outpatient follow-
up and established HAART. However, the patient did not return to her 
scheduled consultations, resulting in an interruption in medical care and, 
consequently, the maintenance treatment, leading to a fatal outcome. 
Seeing as a pulmonary infection, it is considered a rare complication 
in its intestinal form27, combined with the high mortality rate of these 
cases, the lack of formal description of clinical and radiographical 
changes seen upon extra-intestinal localization of this parasite, cause an 
extremely low rate of early diagnosis and untimely treatment.
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